8-K - MBX Biosciences, Inc. Common Stock | StockGist

Current Report Details

Event Type

Management Change

Regulation Fd

Exhibits Only

Disclosure

Mandatory

Variant

8-K

Items Reported

5.02

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. Effective as

Management Change

Ms. Stelzer in the same form as used with the Company

7.01

of this Current Report on Form 8-K, including Exhibit 99.1, is being furnished and shall not be deemed “filed” for the purposes of Section 18 of the Exchange Ac

Regulation Fd

9.01

Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 99.1 Press Release Issued by MBX Biosciences, Inc. on January 22, 2026 104 Cover Page I

Exhibits Only

Source Document

Exhibits (2)

8-K

99.1

EX-99.1